Koninklijke Philips
- Home ›
- NL ›
- Healthcare
Koninklijke Philips N.V. operates as a health technology company worldwide. The last earnings update was 25 days ago. More info.
Add to Portfolio Compare Print
PHIA Share Price and Events
7 Day Returns
1 Year Returns
PHIA Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Koninklijke Philips (PHIA) | -1.1% | 8.1% | 4% | 10.2% | 49.6% | 36.9% |
| Europe Medical Equipment | -0.8% | 4.1% | 6% | 11% | 46.1% | 65.1% |
| NL Market | 0.1% | 6.3% | 4.9% | 1.3% | 27.3% | 26.3% |
1 Year Return vs Industry and Market
- PHIA outperformed the Market in Netherlands which returned 1.3% over the past year.
PHIA Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Koninklijke Philips
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Koninklijke Philips.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 16 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 8.1% |
| Perpetual Growth Rate | 10-Year NL Government Bond Rate | 0.4% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year NL Govt Bond Rate | 0.4% |
| Equity Risk Premium | S&P Global | 9.6% |
| Medical Equipment Unlevered Beta | Simply Wall St/ S&P Global | 0.67 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.666 (1 + (1- 25%) (15.2%)) |
0.742 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.37% + (0.8 * 9.63%) |
8.07% |
Discounted Cash Flow Calculation for ENXTAM:PHIA using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Koninklijke Philips is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Levered FCF (EUR, Millions) | 1,474.09 | 1,811.78 | 2,150.83 | 2,207.00 | 2,105.44 |
| Source | Analyst x9 | Analyst x8 | Analyst x6 | Analyst x1 | Est @ -4.6% |
|
Present Value Discounted (@ 8.07%) |
1,363.97 | 1,551.18 | 1,703.90 | 1,617.77 | 1,428.03 |
| Present value of next 5 years cash flows | €7,664.84 |
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2023
× (1 + g) ÷ (Discount Rate – g)
= €2,105.44 × (1 + 0.37%) ÷ (8.07% – 0.37%) |
€27,430.24 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)5
= €27,430.24 ÷ (1 + 8.07%)5 |
€18,604.74 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 5 years cash flows +
Terminal Value
= €7,664.84 + €18,604.74 |
€26,269.58 |
| Equity Value per Share (EUR) |
= Total value / Shares Outstanding
= €26,269.58 / 913.34 |
€28.76 |
| Calculation | Result | |
|---|---|---|
| Value per share (EUR) | From above. | €28.76 |
| Current discount | Discount to share price of
€34.72
= -1 x (€34.72 - €28.76) / €28.76 |
-20.7% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Koninklijke Philips is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Koninklijke Philips's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Koninklijke Philips's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in EUR | €1.41 |
| ENXTAM:PHIA Share Price ** | ENXTAM (2019-02-22) in EUR | €34.72 |
| Europe Medical Equipment Industry PE Ratio | Median Figure of 55 Publicly-Listed Medical Equipment Companies | 28.92x |
| Netherlands Market PE Ratio | Median Figure of 80 Publicly-Listed Companies | 16.33x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Koninklijke Philips.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = ENXTAM:PHIA Share Price ÷ EPS (both in EUR) = 34.72 ÷ 1.41 |
24.59x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Koninklijke Philips is good value based on earnings compared to the Europe Medical Equipment industry average.
- Koninklijke Philips is overvalued based on earnings compared to the Netherlands market.
Price based on expected Growth
Does
Koninklijke Philips's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 24.59x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts |
13.2%per year |
| Europe Medical Equipment Industry PEG Ratio | Median Figure of 38 Publicly-Listed Medical Equipment Companies | 2.35x |
| Netherlands Market PEG Ratio | Median Figure of 61 Publicly-Listed Companies | 1.63x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 24.59x ÷ 13.2% |
1.86x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Koninklijke Philips is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Koninklijke Philips's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in EUR | €13.22 |
| ENXTAM:PHIA Share Price * | ENXTAM (2019-02-22) in EUR | €34.72 |
| Europe Medical Equipment Industry PB Ratio | Median Figure of 136 Publicly-Listed Medical Equipment Companies | 3.05x |
| Netherlands Market PB Ratio | Median Figure of 102 Publicly-Listed Companies | 1.89x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = ENXTAM:PHIA Share Price ÷ Book Value per Share (both in EUR) = 34.72 ÷ 13.22 |
2.63x |
* Primary Listing of Koninklijke Philips.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Koninklijke Philips is good value based on assets compared to the Europe Medical Equipment industry average.
Value checks
We assess Koninklijke Philips's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check) Koninklijke Philips has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
PHIA Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Koninklijke Philips's earnings growth is expected to exceed the low risk savings rate of 0.4%.
Growth vs Market Checks
- Koninklijke Philips's earnings growth is expected to exceed the Netherlands market average.
- Koninklijke Philips's revenue growth is expected to exceed the Netherlands market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| ENXTAM:PHIA Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts | 13.2% |
| ENXTAM:PHIA Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 16 Analysts | 4.7% |
| Europe Medical Equipment Industry Earnings Growth Rate | Market Cap Weighted Average | 13.3% |
| Europe Medical Equipment Industry Revenue Growth Rate | Market Cap Weighted Average | 7.2% |
| Netherlands Market Earnings Growth Rate | Market Cap Weighted Average | 7.4% |
| Netherlands Market Revenue Growth Rate | Market Cap Weighted Average | 3.3% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 16 Analyst Estimates (S&P Global) | See Below |
| Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 23,266 | 2,592 | 1 | |
| 2022-12-31 | 22,248 | 3,160 | 2,309 | 2 |
| 2021-12-31 | 20,880 | 2,993 | 2,041 | 9 |
| 2020-12-31 | 19,971 | 2,625 | 1,776 | 16 |
| 2019-12-31 | 19,061 | 2,287 | 1,500 | 14 |
| Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 18,121 | 2,427 | 1,303 |
| 2018-09-30 | 17,838 | 1,022 | |
| 2018-06-30 | 17,680 | 2,231 | 871 |
| 2018-03-31 | 17,687 | 3,179 | 808 |
| 2017-12-31 | 17,780 | 2,933 | 814 |
| 2017-09-30 | 17,783 | 830 | |
| 2017-06-30 | 17,792 | 3,193 | 876 |
| 2017-03-31 | 24,724 | 2,526 | 1,105 |
| 2016-12-31 | 17,422 | 3,321 | 788 |
| 2016-09-30 | 19,211 | 3,164 | 218 |
| 2016-06-30 | 20,890 | 2,948 | 248 |
| 2016-03-31 | 22,732 | 1,463 | 365 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 16 Analyst Estimates (S&P Global) | See Below |
All data from Koninklijke Philips Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in EUR Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 2.76 | 2.76 | 2.76 | 1.00 |
| 2022-12-31 | 2.52 | 2.52 | 2.52 | 1.00 |
| 2021-12-31 | 2.18 | 2.47 | 1.95 | 7.00 |
| 2020-12-31 | 1.89 | 2.10 | 1.65 | 10.00 |
| 2019-12-31 | 1.56 | 1.70 | 1.36 | 12.00 |
| Date (Data in EUR Millions) | EPS * |
|---|---|
| 2018-12-31 | 1.41 |
| 2018-09-30 | 1.10 |
| 2018-06-30 | 0.94 |
| 2018-03-31 | 0.87 |
| 2017-12-31 | 0.88 |
| 2017-09-30 | 0.90 |
| 2017-06-30 | 0.95 |
| 2017-03-31 | 1.20 |
| 2016-12-31 | 0.86 |
| 2016-09-30 | 0.24 |
| 2016-06-30 | 0.27 |
| 2016-03-31 | 0.40 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Koninklijke Philips's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Koninklijke Philips has a total score of 3/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
PHIA Past Performance
How has Koninklijke Philips performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Koninklijke Philips's year on year earnings growth rate has been positive over the past 5 years.
- Koninklijke Philips's 1-year earnings growth exceeds its 5-year average (60.1% vs 14.1%)
- Koninklijke Philips's earnings growth has exceeded the Europe Medical Equipment industry average in the past year (60.1% vs 12%).
Earnings and Revenue History
All data from Koninklijke Philips Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in EUR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 18,121.00 | 1,303.00 | 5,131.00 | 1,759.00 |
| 2018-09-30 | 17,838.00 | 1,022.00 | 4,944.00 | 1,662.00 |
| 2018-06-30 | 17,680.00 | 871.00 | 4,915.00 | 1,698.00 |
| 2018-03-31 | 17,687.00 | 808.00 | 4,832.00 | 1,694.00 |
| 2017-12-31 | 17,780.00 | 814.00 | 4,836.00 | 1,692.00 |
| 2017-09-30 | 17,783.00 | 830.00 | 4,754.00 | 1,731.00 |
| 2017-06-30 | 17,792.00 | 876.00 | 4,720.00 | 1,708.00 |
| 2017-03-31 | 24,724.00 | 1,105.00 | 6,594.00 | 2,037.00 |
| 2016-12-31 | 17,422.00 | 788.00 | 4,623.00 | 1,648.00 |
| 2016-09-30 | 19,211.00 | 218.00 | 5,435.00 | 1,741.00 |
| 2016-06-30 | 20,890.00 | 248.00 | 5,920.00 | 1,784.00 |
| 2016-03-31 | 22,732.00 | 365.00 | 6,404.00 | 1,855.00 |
| 2015-12-31 | 16,806.00 | 145.00 | 5,121.00 | 1,562.00 |
| 2015-09-30 | 23,685.00 | 590.00 | 6,470.00 | 1,820.00 |
| 2015-06-30 | 23,043.00 | 228.00 | 6,275.00 | 1,721.00 |
| 2015-03-31 | 22,038.00 | 191.00 | 6,001.00 | 1,638.00 |
| 2014-12-31 | 21,391.00 | 225.00 | 5,930.00 | 1,635.00 |
| 2014-09-28 | 20,373.00 | 437.00 | 5,712.00 | 1,498.00 |
| 2014-06-29 | 20,774.00 | 839.00 | 5,742.00 | 1,575.00 |
| 2014-03-30 | 21,437.00 | 974.00 | 5,834.00 | 1,601.00 |
| 2013-12-31 | 21,990.00 | 1,031.00 | 5,903.00 | 1,657.00 |
| 2013-09-29 | 23,231.00 | 309.00 | 6,019.00 | 1,746.00 |
| 2013-06-30 | 23,457.00 | 132.00 | 6,073.00 | 1,744.00 |
| 2013-03-31 | 23,395.00 | -128.00 | 6,075.00 | 1,758.00 |
| 2012-12-31 | 22,234.00 | -171.00 | 5,957.00 | 1,666.00 |
| 2012-09-30 | 23,410.00 | 466.00 | 6,127.00 | 1,786.00 |
| 2012-07-01 | 22,983.00 | 500.00 | 6,024.00 | 1,728.00 |
| 2012-04-01 | 22,629.00 | -809.00 | 5,994.00 | 1,670.00 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Koninklijke Philips has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Koninklijke Philips used its assets less efficiently than the Europe Medical Equipment industry average last year based on Return on Assets.
- Koninklijke Philips has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Koninklijke Philips's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Koninklijke Philips has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
PHIA Health
How is Koninklijke Philips's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Koninklijke Philips's finances.
The net worth of a company is the difference between its assets and liabilities.
- Koninklijke Philips is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Koninklijke Philips's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is covered by short term assets, assets are 2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Koninklijke Philips Company Filings, last reported 1 month ago.
| Date (Data in EUR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 12,117.00 | 4,821.00 | 1,688.00 |
| 2018-09-30 | 11,700.00 | 4,927.00 | 1,615.00 |
| 2018-06-30 | 11,700.00 | 4,927.00 | 1,615.00 |
| 2018-03-31 | 12,023.00 | 4,716.00 | 1,939.00 |
| 2017-12-31 | 12,023.00 | 4,716.00 | 1,939.00 |
| 2017-09-30 | 12,970.00 | 4,750.00 | 999.00 |
| 2017-06-30 | 13,747.00 | 2,896.00 | 2,220.00 |
| 2017-03-31 | 14,030.00 | 5,344.00 | 2,731.00 |
| 2016-12-31 | 13,453.00 | 5,606.00 | 2,334.00 |
| 2016-09-30 | 12,473.00 | 5,768.00 | 1,859.00 |
| 2016-06-30 | 12,341.00 | 5,808.00 | 1,926.00 |
| 2016-03-31 | 11,409.00 | 5,689.00 | 1,385.00 |
| 2015-12-31 | 11,780.00 | 5,760.00 | 1,766.00 |
| 2015-09-30 | 11,554.00 | 5,547.00 | 1,038.00 |
| 2015-06-30 | 11,511.00 | 5,680.00 | 1,139.00 |
| 2015-03-31 | 11,496.00 | 5,785.00 | 1,792.00 |
| 2014-12-31 | 10,968.00 | 4,104.00 | 1,873.00 |
| 2014-09-28 | 11,001.00 | 4,309.00 | 1,842.00 |
| 2014-06-29 | 10,758.00 | 3,768.00 | 1,560.00 |
| 2014-03-30 | 11,025.00 | 3,717.00 | 1,738.00 |
| 2013-12-31 | 11,227.00 | 3,901.00 | 2,475.00 |
| 2013-09-29 | 10,951.00 | 4,066.00 | 2,044.00 |
| 2013-06-30 | 10,802.00 | 4,411.00 | 2,308.00 |
| 2013-03-31 | 11,197.00 | 4,602.00 | 3,067.00 |
| 2012-12-31 | 11,185.00 | 4,534.00 | 3,834.00 |
| 2012-09-30 | 12,081.00 | 4,696.00 | 3,232.00 |
| 2012-07-01 | 12,177.00 | 4,900.00 | 3,134.00 |
| 2012-04-01 | 12,287.00 | 5,012.00 | 4,225.00 |
- Koninklijke Philips's level of debt (39.8%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (34.7% vs 39.8% today).
- Debt is well covered by operating cash flow (50.3%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 10.3x coverage).
Financial health checks
We assess Koninklijke Philips's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Koninklijke Philips has a total score of 5/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
PHIA Dividends
What is Koninklijke Philips's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
€2,000 of
Koninklijke Philips
shares you are expected to receive
€49
in your first year as a dividend.
Dividend Amount
- Koninklijke Philips's pays a lower dividend yield than the bottom 25% of dividend payers in Netherlands (2.47%).
- Koninklijke Philips's dividend is below the markets top 25% of dividend payers in Netherlands (5.92%).
Upcoming dividend payment
Purchase Koninklijke Philips on or before the 'Buy Limit' to receive their next dividend payment.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 16 Analyst Estimates (S&P Global) | See Below |
| Europe Medical Equipment Industry Average Dividend Yield | Market Cap Weighted Average of 40 Stocks | 1.6% |
| Netherlands Market Average Dividend Yield | Market Cap Weighted Average of 67 Stocks | 4% |
| Netherlands Minimum Threshold Dividend Yield | 10th Percentile | 1.6% |
| Netherlands Bottom 25% Dividend Yield | 25th Percentile | 2.5% |
| Netherlands Top 25% Dividend Yield | 75th Percentile | 5.9% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in €) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | 1.00 | 1.00 |
| 2021-12-31 | 1.00 | 8.00 |
| 2020-12-31 | 0.90 | 15.00 |
| 2019-12-31 | 0.85 | 15.00 |
| Date (Data in €) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-01-29 | 0.850 | 2.485 |
| 2018-02-20 | 0.800 | 2.325 |
| 2018-01-30 | 0.800 | 2.569 |
| 2017-02-21 | 0.800 | 2.488 |
| 2017-01-24 | 0.800 | 2.911 |
| 2016-02-23 | 0.800 | 3.179 |
| 2016-01-26 | 0.800 | 3.532 |
| 2015-02-24 | 0.800 | 3.301 |
| 2015-01-27 | 0.800 | 3.179 |
| 2014-05-02 | 0.800 | 3.436 |
| 2013-05-06 | 0.750 | 3.081 |
| 2012-02-23 | 0.750 | 4.146 |
| 2012-01-30 | 0.750 | 4.762 |
| 2011-03-31 | 0.750 | 4.711 |
| 2010-02-22 | 0.700 | 2.976 |
| 2010-01-25 | 0.700 | 3.231 |
| 2009-02-24 | 0.700 | 4.563 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Dividends per share have been stable in the past 10 years.
- Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of
Koninklijke Philips's earnings are
paid
to the shareholders as a dividend.
- Dividends paid are covered by earnings (1.7x coverage).
- Dividends after 3 years are expected to be well covered by earnings (2.5x coverage).
Income/ dividend checks
We assess Koninklijke Philips's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Koninklijke Philips afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Koninklijke Philips has a total score of 4/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
PHIA Management
CEO
| COMPENSATION | €5,101,429 |
| AGE | 58 |
| TENURE AS CEO | 7.8 years |
CEO Bio
Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serves as the Chief Executive Officer at Philips International B.V. He has been the Chairman of the Board of Management, Chief Executive Officer and President at Koninklijke Philips N.V. April 2011. He has been the Chairman of Management Board and Chief Executive Officer of Philips Electronics Australia Limited since November 2011 and also serves as its Member of Management Board. He serves as the Chief Executive Officer and President of Philips Electronics NV. He served as Temporary Advisor to Management Board at ASM International NV since March 2009. In 2009 and 2010, he was a consultant to the boards of companies such as ING Group NV and ASM International NV. He supported ASM’s management Board in its on-going efforts to ensure it has the strongest operational framework with which to withstand current extreme economic and industry conditions. Previously, he also served as a Member of Board of Management at Koninklijke Philips N.V. since April 1, 2006. He served as an Acting Chief Executive Officer/Chief Executive Officer of Philips Lighting Limited of Koninklijke until March 20, 2012. He served as the Chief Executive Officer at NXP Semiconductors Netherlands B.V. He served as the Chairman of Management Board, Chief Executive Officer and President of NXP Semiconductors NV from November 2004 to January 1, 2009 and served as its Member of Management Board. Prior to re-joining Philips late 2010, he was leading the project to separate ING Group’s banking and insurance operations as an Independent Advisor to ING’s management board. He served as an Acting Chief Executive Officer of Philips LumiLeds Lighting Company LLC. He served as the President and Chief Executive Officer of NXP B.V. (formerly, Philips Semiconductors BV) from November 1, 2004 to January 1, 2009. He served as the Chairman and Member of Management Board of NXP until January 2009. Mr. van Houten served as Senior Vice President of Royal Philips Electronics of Koninklijke Philips N.V. He also served as the Co-Chief Executive Officer of Philips Consumer Electronics Business Groups since July 21, 2003. He served as an Executive Vice President of Philips Consumer Electronics of Philips Electronics Asia Pacific Pvt. Ltd., Singapore. He served as the General Manager of Global Business Creation at Philips Consumer Electronics. He started his career with Philips in 1986 in marketing and sales at Philips Data Systems. He served as the Chief Executive Officer of Philips Airvision, a small in-flight entertainment start-up. From 1993 to 1996, he served as Vice President of International Sales & Operations of the Communication Network Systems Division at PKI (Philips Kommunikations Industrie) in Germany, providing solutions to Telecom Operators. In 1996, he joined Philips Consumer Electronics in Eindhoven to set up the Disc Systems Business Unit and to lead the global birth of two product categories: Audio CD Recording and DVD Video. Two years later, he also served as the Chief Operating Officer of the Digital Video Group at Philips in Palo Alto, California and served as its Executive Vice President of Consumer Electronics for the regions of Asia Pacific and Middle East & Africa since 1999. He was Vice Chairman of Supervisory Board at Philips Lighting N.V. since May 2016 until December 31, 2017 and was its Member of Supervisory Board since 2016 until December 31, 2017. He served as Vice Chairman and Director of LG Display Co., Ltd. (also known as L.G. Phillips LCD Co. Ltd.) since December 2003. He has been Independent Non-Executive Director of Novartis AG since February 28, 2017. He serves as a Director of Philips Electronics Shanghai and Philips Electronics Indonesia. He serves as a Non-Executive Member of the Supervisory Board of LG. Phillips Displays Holding B.V. He served as a Director of LG Display since December 2003. He served as a Non-Executive Director of Philips Electronics India Limited (now Philips India Limited) from July 22, 1999 to July 26, 2002 and a Director at NXP B.V. until December 31, 2008. He has been a Member of the European Round Table of Industrialists since October 2010. Mr. van Houten received his Undergraduate Degree in Economics, Marketing and Business Management. He holds a Master’s Degree in Business Administration/Master’s Degree in Economics and Business Management from Erasmus University of Rotterdam.
CEO Compensation
- Frans's compensation has been consistent with company performance over the past year.
- Frans's remuneration is higher than average for companies of similar size in Netherlands.
Management Team Tenure
Average tenure and age of the Koninklijke Philips management team in years:
- The tenure for the Koninklijke Philips management team is about average.
Management Team
Frans van Houten
Chairman of the Board of Management
€5M
58
7.8 yrs
Christine Poon
Vice-Chairman of the Supervisory Board & Secretary
€140K
66
Abhijit Bhattacharya
Executive VP
€2M
57
3.3 yrs
Marnix van Ginneken
Executive VP
€306K
45
1.3 yrs
Sophie Bechu
Executive VP & Chief of Operations
58
2.4 yrs
Pim Preesman
Head of Investor Relations
Ronald de Jong
Chief HR Officer & Executive VP
51
1.8 yrs
Sean Carney
Chief Design Officer
7.3 yrs
Roy Jakobs
Chief Business Leader of Personal Health Business
44
0.3 yrs
Jeroen Tas
Chief Innovation & Strategy Officer and Executive VP
59
2.6 yrs
Board of Directors Tenure
Average tenure and age of the Koninklijke Philips board of directors in years:
- The tenure for the Koninklijke Philips board of directors is about average.
Board of Directors
Jeroen van der Veer
Chairman of the Supervisory Board
€167K
71
7.9 yrs
Christine Poon
Vice-Chairman of the Supervisory Board & Secretary
€140K
66
Heino von Prondzynski
Member of Supervisory Board
€132K
69
12.1 yrs
Jack Tai
Member of the Supervisory Board
€145K
68
8.1 yrs
Neelam Dhawan
Member of Supervisory Board
€120K
59
6.8 yrs
Orit Gadiesh
Member of Supervisory Board
€113K
67
4.8 yrs
David E. Pyott
Member of Supervisory Board
€135K
65
3.8 yrs
Paul Stoffels
Member of Supervisory Board
56
0.5 yrs
A. Harrison
Member of Supervisory Board
54
0.3 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (€) | Value (€) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Koninklijke Philips's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Koninklijke Philips has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
PHIA News
Simply Wall St News
Does The Data Make Koninklijke Philips N.V. (AMS:PHIA) An Attractive Investment?
(AMS:PHIA) is a company with exceptional fundamental characteristics. … Upon building up an investment case for a stock, we should look at various aspects. … In the case of PHIA, it
Simply Wall St - – Full articleOne Factor To Consider Before Investing In Koninklijke Philips N.V. (AMS:PHIA)
I will take you through Koninklijke Philips’s cash flow health and the risk-return concept based on the stock’s cash flow yield, using the most recent financial data. … Koninklijke Philips’s free cash flow (FCF) is the level of cash flow the business generates from its operational activities, after it reinvests in the company as capital expenditure. … The two ways to assess whether Koninklijke Philips’s FCF is sufficient, is to compare the FCF yield to the market index yield, as well as determine whether the top-line operating cash flows will continue to grow
Simply Wall St - – Full articleIs Koninklijke Philips N.V. (AMS:PHIA) A Smart Choice For Dividend Investors?
The stock currently pays out a dividend yield of 2.6%, and has a market cap of €29b. … Does Koninklijke Philips tick all the boxes of a great dividend stock? … See our latest analysis for Koninklijke Philips
Simply Wall St - – Full articleDoes Koninklijke Philips N.V.'s (AMS:PHIA) Recent Track Record Look Strong?
Today I will take a look at Koninklijke Philips N.V.'s (AMS:PHIA) most recent earnings update (30 September 2018) and compare these latest figures against its performance over the past few years, as well as how the rest of the medical equipment industry performed. … How Did PHIA's Recent Performance Stack Up Against Its Past. … PHIA's trailing twelve-month earnings (from 30 September 2018) of €1.0b has.
Simply Wall St - – Full articleWhat Does Koninklijke Philips NV's (AMS:PHIA) Share Price Indicate?
received a lot of attention from a substantial price movement on the ENXTAM over the last few months, increasing to €39.72 at one point, and dropping to the lows of €31.33. … A question to answer is whether Koninklijke Philips's current trading price of €33.77 reflective of the actual value of the? … Let’s take a look at Koninklijke Philips’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleCan We See Significant Institutional Ownership On The Koninklijke Philips NV (AMS:PHIA) Share Register?
The big shareholder groups in Koninklijke Philips NV (AMS:PHIA) have power over the company. … Companies that used to be publicly owned tend to have lower insider ownership. … With a market capitalization of €30b, Koninklijke Philips is rather large.
Simply Wall St - – Full articleIs Koninklijke Philips NV's (AMS:PHIA) ROE Of 9.1% Concerning?
By way of learning-by-doing, we'll look at ROE to gain a better understanding Koninklijke Philips NV (AMS:PHIA). … One way to conceptualize this, is that for each €1 of shareholders' equity it has, the company made €0.091 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleDo You Know What Koninklijke Philips NV's (AMS:PHIA) P/E Ratio Means?
Based on the last twelve months, Koninklijke Philips's P/E ratio is 29.11. … How Do I Calculate Koninklijke Philips's Price To Earnings Ratio … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleWhat does Koninklijke Philips NV's (AMS:PHIA) Balance Sheet Tell Us About Its Future?
There are a number of reasons that attract investors towards large-cap companies such as Koninklijke Philips NV (AMS:PHIA), with a market cap of €32.4b. … Let’s take a look at Koninklijke Philips’s leverage and assess its financial strength to get an idea of their ability to fund strategic acquisitions and grow through cyclical pressures. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis
Simply Wall St - – Full articleEstimating The Intrinsic Value Of Koninklijke Philips NV (AMS:PHIA)
by taking the expected future cash flows and discounting them to their present value. … discounted cash flows (DCF). … If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model
Simply Wall St - – Full articlePHIA Company Info
Map
Description
Koninklijke Philips N.V. operates as a health technology company worldwide. The company offers mother and child care, and oral healthcare products; male grooming and beauty products; kitchen appliance, coffee, air, garment care, and floor care products; and sleep, respiratory care, and respiratory drug delivery products. It also provides diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. In addition, the company offers interventional X-ray systems, and imaging and therapy devices for the treatment of coronary artery and peripheral vascular disease; imaging products that focus on diagnosis, treatment planning, and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; and proprietary software to enable diagnostics and intervention. Further, it provides enterprise wide patient monitoring solutions; patient analytics and monitoring, and clinical decision support systems; therapeutic care products; patient monitoring and therapeutic care consumables; and customer services. Additionally, the company offers healthcare information technology (IT), clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology departments; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. It also provides digital platforms that connect consumers, patients, and healthcare providers in a cloud-based connected health ecosystem of devices, apps, and tools. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Details
| Name: | Koninklijke Philips N.V. |
| PHIA | |
| Exchange: | ENXTAM |
| Founded: | 1891 |
| €31,711,036,544 | |
| 913,336,306 | |
| Website: | http://www.philips.com |
| Address: |
Koninklijke Philips N.V. Breitner Center, Amstelplein 2, Amsterdam, Noord-Holland, 1096 BC, Netherlands |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| ENXTAM | PHIA | Common Shares | Euronext Amsterdam | NL | EUR | 18. Dec 1980 | |
| OTCPK | RYLP.F | Common Shares | Pink Sheets LLC | US | USD | 18. Dec 1980 | |
| DB | PHI1 | Common Shares | Deutsche Boerse AG | DE | EUR | 18. Dec 1980 | |
| XTRA | PHI1 | Common Shares | XETRA Trading Platform | DE | EUR | 18. Dec 1980 | |
| LSE | 0LNG | Common Shares | London Stock Exchange | GB | EUR | 18. Dec 1980 | |
| SWX | PHI | Common Shares | SIX Swiss Exchange | CH | CHF | 18. Dec 1980 | |
| BIT | PHIA | Common Shares | Borsa Italiana | IT | EUR | 18. Dec 1980 | |
| WBAG | PHIA | Common Shares | Wiener Boerse AG | AT | EUR | 18. Dec 1980 | |
| BMV | PHIA N | Common Shares | Bolsa Mexicana de Valores | MX | MXN | 18. Dec 1980 | |
| BATS-CHIXE | PHIAA | Common Shares | BATS 'Chi-X Europe' | GB | EUR | 18. Dec 1980 | |
| NYSE | PHG | NY REG SH NEW | New York Stock Exchange | US | USD | 02. Jan 1980 | |
| DB | PHIA | NY REG SH NEW | Deutsche Boerse AG | DE | EUR | 02. Jan 1980 | |
| XTRA | PHIA | NY REG SH NEW | XETRA Trading Platform | DE | EUR | 02. Jan 1980 |
Number of employees
Current staff
Industry
| Health Care Equipment | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/02/23 20:46 |
| End of day share price update: | 2019/02/22 00:00 |
| Last estimates confirmation: | 2019/02/12 |
| Last earnings filing: | 2019/01/29 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
